Express Pharma - Page 1018 of 1139 - Express Pharma

Lonza Capsugel celebrates 25 years of its category-defining joint health solution: UC-II® undenatured type II collagen

Leiutis marks milestone with CDSCO approval for Synthetic Cannabidiol Oral Solution for mild to moderate anxiety disorders

Express Pharma CPHI

Glenmark initiates IND enabling studies of novel monoclonal antibody targeting OX40

Marck Biosciences takes private equity route with Tata Capital

Lonza commences manufacturing in cGMP Viral Immunotherapy manufacturing suites

Medicines Compendium expands global reach through new expert committees, enhanced website

Lonza and Novoset launches thermoset polyimides for electronic and aerospace industries

February 1-15, 2013

Lupin posts net profit of 42.6 per cent in Q3 of 2012-13

Global Drug Facility appoints Dr Joel Keravec as manager

Patent Gurukul, Pravin Gandhi College of Law to organise brainstorming session on traditional knowledge and biodiversity

Glenmark’s total income increased to Rs13.8 billion in Q3FY13